March 24th, 2021 by Chassin
A clinical research study is currently recruiting adults in the US and Canada.
The preliminary requirements to participate in this study of an oral investigational drug are:
- • Adults ages 18-65
- • A diagnosis of alopecia areata
- • 50% or greater scalp hair loss
For more detailed clinical information visit https://bgdl.org/THRIVE-AA1.
Bald Girls Do Lunch is providing this announcement for informational purposes only. Bald Girls Do Lunch does not imply endorsement. The decision to participate is voluntary and wholly the responsibility of the individual person.
June 1st, 2020 by Chassin
Ms. Paige Clarke-Jeffers announces the enrollment of Black women with all forms of alopecia areata in her research project: “Black Women’s Experiences of Living with Alopecia” at Birmingham City University, United Kingdom. The study is for her Masters of Health Psychology dissertation.
November 2nd, 2019 by Chassin
Shannon’s Story from Concert Pharmaceuticals, Inc on Vimeo.
You’re not alone if you’re wondering how do I cope with alopecia areata knowing there’s no alopecia cure? One way to feel supported is right here: watching and reading personal stories — people like yourself living with alopecia.
Watch Shannon’s heartfelt story: how she talks to herself and to others.
We thank Concert Pharmaceuticals for including our Bald Girls ambassador, Shannon, in their patient web portal for alopecia areata at ConcertPharma.com/patients/
March 11th, 2018 by Chassin
As part of our Bald Girls community, you know firsthand the impacts of alopecia areata. That’s also what the FDA wants to learn. They held an AA patient-focused meeting in September 2017 attended by Bald Girls Do Lunch CEO, Thea Chassin.
January 18th, 2017 by Chassin
Researchers at the University of Sheffield’s Department of Psychology want to hear from you!
Will a self-help program aid patients with visible skin differences?
Be part of the survey this week. You might win a very nice Amazon Gift card chosen from all participants. Register HERE Learn more HERE.
August 9th, 2016 by Chassin
Dept of Dermatology Researchers, Icahn School of Medicine, Mount Sinai Health System
Here at Mount Sinai School of Medicine, it is an exciting time for treatment in alopecia areata. Currently we have three trials going on: an injectable, a topical and an oral. Read More
April 23rd, 2016 by Chassin
Mount Sinai ( New York ) has options for alopecia areata patients
Is there a cure for alopecia areata? No, there is no cure, but researchers are doing clinical trials in search of safe and effective alopecia treatments. Dr. Emma Guttman, in New York is conducting several studies including a pilot study with Tralokinumab for moderate to severe alopecia areata.
Follow along with our interview so you can talk to your friends and family about new studies for alopecia treatment… Read More
March 18th, 2016 by Chassin
Alopecia Areata research is of great interest to people with this autoimmune skin disorder. This Bald Girls Do Lunch blog informs you with patient-friendly posts on alopecia areata news, clinical trials and popular posts like our features on Tofacitinib and Ruxolitinib. In 2016…Read More
February 14th, 2016 by Chassin
Research & Treatment Posts in BGDL Alopecia Areata Support Blog
Sign Up Today to be in the know when we publish an update series on the Mount Sinai Medical Center clinical trials. Watch your inbox for news about Dr. Emma Guttman, Dermatology Researcher for the Mount Sinai School of Medicine.